Dmsa Research Team Entry Assessment Quiz

20 Questions | Total Attempts: 50

SettingsSettingsSettings
Dmsa Research Team Entry Assessment Quiz - Quiz

This exam is produced by DMSA research team to assess the knowledge of the members on the fundamentals of clinical research skills. Al-Azhar University Damietta faculty of medicine Damietta medical student association (DMSA) research team


Questions and Answers
  • 1. 
    Pre-clinical research is
    • A. 

      Done on healthy human volunteers

    • B. 

      Done using lab animals

    • C. 

      Done on group of diseased human participants

    • D. 

      Developed from patient records

  • 2. 
    All of the following studies have prospective design except
    • A. 

      Case-control study

    • B. 

      Randomized controlled trial

    • C. 

      Quasi control study

    • D. 

      Classical cohort study

  • 3. 
    In double-blind randomized controlled trial
    • A. 

      The doctors know but the patients don’t know who is getting placebo

    • B. 

      Neither the doctor nor the patients know who is getting the placebo

    • C. 

      Both doctors and patients know who is getting placebo

    • D. 

      Patients know but the doctors don’t know who is getting placebo

  • 4. 
    A placebo is
    • A. 

      Drug pill looks the same as the drug being tested

    • B. 

      Drug bill containing the same chemicals in the drug being tested

    • C. 

      False pill contains no active ingredients and looks the same as the active pill

    • D. 

      Drug pill which has lower concentration of the active ingredients

  • 5. 
    The most important document to enrol patients in clinical trial is
    • A. 

      Protocol

    • B. 

      Informed consent

    • C. 

      Case report form

    • D. 

      Patient marital status documents

  • 6. 
    For what purpose does the IRB review the informed consent?
    • A. 

      Protection of the facility

    • B. 

      Protection of the participant

    • C. 

      For documentation

    • D. 

      Protection of the sponsor

  • 7. 
    When is the primary outcome/endpoint of the trial defined?
    • A. 

      Just prior to data analysis

    • B. 

      During protocol development

    • C. 

      At randomization

    • D. 

      At final evaluation of data

  • 8. 
    One main reason for drop-out of a new drug under clinical testing is
    • A. 

      Side effects

    • B. 

      High efficacy

    • C. 

      Drug-food interaction

    • D. 

      Secreted in urine

  • 9. 
    The source of strongest evidence in  EBM pyramid is
    • A. 

      Expert opinion

    • B. 

      Systematic review and meta-analysis

    • C. 

      Case report

    • D. 

      Randomized controlled study

  • 10. 
    Systematic review and meta-analysis methodology usually doesn’t include
    • A. 

      Screening of clinical trial articles

    • B. 

      Blinding of reviewers

    • C. 

      Data analysis

    • D. 

      Quality assessment

  • 11. 
    The usual format of journal research article is
    • A. 

      Introduction, abstract, methods, and references

    • B. 

      Abstract, introduction, methods, results, discussion, and references

    • C. 

      Introduction, results, discussion, and methods.

    • D. 

      Introduction, Methods, results, abstract, references, and discussion

  • 12. 
    The section contains details on the dosages and administration data usually is
    • A. 

      Introduction

    • B. 

      Abstract

    • C. 

      Methods

    • D. 

      Discussion

  • 13. 
    The section usually doesn’t need citations is
    • A. 

      Discussion

    • B. 

      Abstract

    • C. 

      Introduction

    • D. 

      Results

  • 14. 
    Which of the following is not a Qualitative variable  
    • A. 

      Age

    • B. 

      Marital status

    • C. 

      Blood groups

    • D. 

      Gender

  • 15. 
    Which of the following is not a measure of central tendency
    • A. 

      Standard deviation

    • B. 

      Mean

    • C. 

      Mode

    • D. 

      Median

  • 16. 
    Standard deviation is usually used to describe data spread around
    • A. 

      Median

    • B. 

      Mean

    • C. 

      Mode

    • D. 

      P-value

  • 17. 
    Normal distribution curve is characterized by all of the following except
    • A. 

      Bell shaped curve

    • B. 

      Can be described by mean and standard deviation

    • C. 

      Data are not symmetrical around the mean

    • D. 

      Mean, median, and mode are equal

  • 18. 
    In normal distribution curve, the area represented by mean plus two standard deviations above or below (mean±2SD) contains
    • A. 

      90% of sample data

    • B. 

      50% of sample data

    • C. 

      99% of sample data

    • D. 

      95.4% of sample data

  • 19. 
    Typically to reject the null hypothesis the P-value must be
    • A. 

      Lower than 0.05

    • B. 

      Lower than or equal to 0.05

    • C. 

      Lower than or equal to 0.5

    • D. 

      Above or equal to 0.5

  • 20. 
    If we are using risk ratio as effect estimate which of the following 95% confidence intervals is statistically significant?
    • A. 

      [1, 1.88]

    • B. 

      [0.5, 0.8]

    • C. 

      [0.01, 2]

    • D. 

      [0.98, 5]

Back to Top Back to top